Advertisement
Screener

Johnson & Johnson (JNJ) ROE

JOHNSON & JOHNSON ROE

Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • JOHNSON & JOHNSON roe for the quarter ending 2026-06-28 was 24.76%, a 14.27% decline year-over-year.
  • JOHNSON & JOHNSON roe for the quarter ending 2026-03-29 was 25.92%, a 7.19% decline year-over-year.
  • JOHNSON & JOHNSON roe for the quarter ending 2025-12-28 was 32.87%, a 67.06% increase year-over-year.
  • JOHNSON & JOHNSON roe for the quarter ending 2025-09-28 was 31.69%, a 51.39% increase year-over-year.
  • JOHNSON & JOHNSON roe for fiscal 2025 was 32.87%, a 67.06% increase from fiscal 2024.
  • JOHNSON & JOHNSON roe for fiscal 2024 was 19.68%, a 61.51% decline from fiscal 2023.
  • JOHNSON & JOHNSON roe for fiscal 2023 was 51.11%, a 118.81% increase from fiscal 2023.
  • JOHNSON & JOHNSON roe for fiscal 2023 was 23.36%, a 17.18% decline from fiscal 2022.
Available history
2011-01-02 to 2026-06-28
Data captured

Historical ROE

DateROENet income 12 monthNet income 3 monthShareholder equity
2026-06-2824.76%$21.04B$5.53B$84.97B
2026-03-2925.92%$21.04B$5.24B$81.19B
2025-12-2832.87%$26.8B$5.12B$81.54B
2025-09-2831.69%$25.12B$5.15B$79.28B
2025-06-2928.88%$22.66B$5.54B$78.47B
2025-03-3027.92%$21.81B$11.00B$78.11B
2024-12-2919.68%$14.07B$3.43B$71.49B
2024-09-2920.93%$14.68B$2.69B$70.16B
2024-06-3053.14%$38.02B$4.69B$71.54B
2024-03-3154.95%$38.48B$3.25B$70.02B
2023-12-3151.11%$35.15B$4.05B$68.77B
2023-10-0148.61%$34.62B$26.03B$71.23B
2023-07-0217.08%$13.05B$5.14B$76.41B
2023-04-0217.95%$12.72B-$68.00M$70.87B
2023-01-0123.36%$17.94B$3.52B$76.8B
2022-10-0225.68%$19.16B$4.46B$74.6B
2022-07-0324.05%$18.37B$4.81B$76.36B
2022-04-0326.54%$19.83B$5.15B$74.71B
2022-01-0228.20%$20.88B$4.74B$74.02B
2021-10-0325.44%$17.88B$3.67B$70.27B
2021-07-0425.53%$17.77B$6.28B$69.58B
2021-04-0422.96%$15.12B$6.20B$65.83B
2021-01-0323.25%$14.71B$1.74B$63.28B
2020-09-2726.35%$16.99B$3.55B$64.47B
2020-06-2824.11%$15.19B$3.63B$62.98B
2020-03-2928.01%$17.17B$5.80B$61.29B
2019-12-2925.42%$15.12B$4.01B$59.47B
2019-09-2924.31%$14.15B$1.75B$58.21B
2019-06-3026.87%$16.33B$5.61B$60.79B
2019-03-3124.90%$14.68B$3.75B$58.96B
2018-12-3025.60%$15.3B$3.04B$59.75B
2018-09-302.39%$1.54B$3.93B$64.63B
2018-07-012.18%$1.37B$3.95B$62.89B
2018-04-011.97%$1.25B$4.37B$63.26B
2017-12-312.16%$1.3B-$10.71B$60.16B
2017-10-0121.39%$15.83B$3.76B$73.98B
2017-07-0222.71%$16.34B$3.83B$71.92B
2017-04-0223.46%$16.51B$4.42B$70.34B
2017-01-0123.49%$16.54B$3.81B$70.42B
2016-10-0221.91%$15.94B$4.27B$72.77B
2016-07-0320.73%$15.03B$4.00B$72.47B
2016-04-0321.40%$15.55B$4.46B$72.65B
2016-01-0321.66%$15.41B$3.21B$71.15B
2015-09-2720.56%$14.72B$3.36B$71.55B
2015-06-2822.64%$16.11B$4.52B$71.13B
2015-03-2923.45%$15.92B$4.32B$67.88B
2014-12-2823.40%$16.32B$2.52B$69.75B
2014-09-2822.61%$17.32B$4.75B$76.59B
2014-06-2919.93%$15.55B$4.33B$78.05B
2014-03-3019.67%$15.06B$4.73B$76.58B
2013-12-2918.68%$13.83B$3.52B$74.05B
2013-09-2918.45%$12.88B$2.98B$69.8B
2013-06-3018.47%$12.87B$3.83B$69.67B
2013-03-3115.62%$10.44B$3.50B$66.86B
2012-12-3016.74%$10.85B$2.57B$64.83B
2012-09-3013.34%$8.5B$2.97B$63.76B
2012-07-0114.46%$8.74B$1.41B$60.43B

Annual ROE

DateROENet income 12 monthShareholder equity
2025-12-2832.87%$26.8B$81.54B
2024-12-2919.68%$14.07B$71.49B
2023-12-3151.11%$35.15B$68.77B
2023-01-0123.36%$17.94B$76.8B
2022-01-0228.20%$20.88B$74.02B
2021-01-0323.25%$14.71B$63.28B
2019-12-2925.42%$15.12B$59.47B
2018-12-3025.60%$15.3B$59.75B
2017-12-312.16%$1.3B$60.16B
2017-01-0123.49%$16.54B$70.42B
2016-01-0321.66%$15.41B$71.15B
2014-12-2823.40%$16.32B$69.75B
2013-12-2918.68%$13.83B$74.05B
2012-12-3016.74%$10.85B$64.83B
2012-01-0116.94%$9.67B$57.08B
2011-01-0223.57%$13.33B$56.58B

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ELI LILLY & Co (LLY)United States$1,113.804B42.28
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38